Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |